The anatomic extent and completeness of pelvic lymphadenectomy is what matters

Current Opinion in Urology

Volumn 23, Issue 5, 2013, Pages 444-448

  Pohar, Kamal S ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; Lymphadenectomy; Survival

Indexed keywords

CHOLINE C 11; CHOLINE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PHASE 3 CLINICAL TRIAL (TOPIC); PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STANDARDIZATION; SURGICAL ANATOMY;

EID: 84881668626     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e328363f5f8     Document Type: Review

References (21)

1. Roth B, Wissmeyer MP, Zehnder P, et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010; 57:205-211
2. Herr HW, Bochner BH, Dalbagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167:1295-1298
3. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 2003; 169:946-950
4. Dorin RP, Daneshmand S, Eisenberg MS, et al. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: A comparative mapping study. Eur Urol 2011; 60:946-952
5. Meijer RPP, Nunnink CJM, Wassenaar AE, et al. Standard lymph node dissection for bladder cancer: Significant variability in the number of reported lymph nodes. J Urol 2012; 187:446-450
6. Gordetsky J, Scosyrev E, Rashid H, et al. Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens. Mod Path 2012; 25:140-144
7. Leissner J, Ghoneim MA, Abol-Enein H, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: Results of a prospective multicenter study. J Urol 2004; 171:139-144
8. Dangle PP, Gong MC, Bahnson RR, Pohar KS. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 2010; 183:499-503
9. Morgan TM, Barocas DA, Penson DF, et al. Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Urology 2012; 80:632-640
10. Rink M, Shariat SF, Xylinas E, et al. Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol 2012; 30:807-814
11. Johnson MT, Hade EM, Calhoun A, et al. Number of lymph nodes removed does not influence survival in stage N0 bladder cancer after complete extended lymphadenectomy [Abstract]. (Presented at the Annual Meeting of the American Urological Association; May 2012 Atlanta Georgia.). J Urol 2012; 187:A1908
12. Dhar NB, Klein EA, Reuther AM, et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179:873-878
13. Zehnder P, Studer UE, Skinner EC, et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: A comparative study. J Urol 2011; 186:1261-1268
14. Abol-Enein H, Tilki D, Mosbah A, et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 2011; 60:572-577
15. Jensen JB, Ulhoi BP, Jensen KM. Extended versus limited lymph node dissection in radical cystectomy: Impact on recurrence pattern and survival. Int J Urol 2012; 19:39-47
16. Jensen JB, Ulhoi BP, Jensen KM. Evaluation of different lymph node variables as prognostic markers in patients undergoing radical cystectomy and extended lymph node dissection to the level of the inferior mesenteric artery. BJU Int 2011; 109:388-393
17. Tarin TV, Power NE, Ehdaie B, et al. Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: Effect of the level of node positivity. Eur Urol 2012; 61:1025-1030
18. Bruins HM, Dorin RP, Rubino B, et al. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy. Eur Urol 2012; 62:671-676
19. Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009; 55:761-769
20. Kibel AS, Dehdashti F, Matthew DK, et al. Prospective study of [18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. JCO 2009; 27:4314-4320
21. Maurer T, Souvatzoglou M, Kubler H, et al. Diagnostic efficacy of [11C] choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 2012; 61:1031-1038